Search Virginia Mason News

Seattle, WA - (Jan. 31, 2012) Benaroya Research Institute at Virginia Mason (BRI) recently announced Jane Buckner, MD, as Associate Director, a position created to support the significant growth of the Institute in the last several years. Dr. Buckner will provide leadership support for the Kenneth R. Wilske Center for Translational Research at Virginia Mason and oversight of BRI Business Development and Core Laboratories. Additionally, Dr. Buckner is Program Director for Translational Research and a Principal Investigator at BRI.

Dr. Buckner joined BRI in 1999 and is internationally recognized for her research in understanding the immunologic and genetic causes of autoimmune diseases including Type 1 diabetes, multiple sclerosis (MS), rheumatoid arthritis, lupus and relapsing polychondritis. Dr. Buckner sees patients with rheumatic diseases at the Virginia Mason Clinic and at the University of Washington as a clinical associate professor of medicine.

About Benaroya Research Institute at Virginia Mason
Benaroya Research Institute at Virginia Mason (BRI), founded in 1956, is an international leader in immune system and autoimmune disease research, translating discoveries to real-life applications. BRI is one of the few research institutes in the world dedicated to discovering causes and cures to eliminate autoimmune diseases such as Type 1 diabetes, multiple sclerosis, arthritis and many others. Visit BenaroyaResearch.org or Facebook/BenaroyaResearch for more information about BRI, clinical studies and the more than 80 different types of autoimmune diseases.

Media Contact: For more information, contact Kay Branz, BRI Director of Communications at 206-342-6903.

Back to Search